Improving Vancomycin Therapeutic Drug Monitoring With a Deep Learning-Based Two-Compartment Predictive Model: Development and Validation Study. [PDF]
Mao B, Xie Z, Rasmy L, Nigo M, Zhi D.
europepmc +1 more source
Staphylococcus aureus With Reduced Vancomycin Susceptibility: Diagnostic Challenges in Clinical Settings. [PDF]
Jadhav MB, Karande G, Patil S.
europepmc +1 more source
Pre-sterilization of vancomycin-loaded cement spacers: impact on antibacterial efficacy against Staphylococcus aureus. [PDF]
Chulsomlee K +5 more
europepmc +1 more source
Association between concomitant use of vancomycin-piperacillin/tazobactam and acute kidney injury in real-world setting. [PDF]
Wang CH, Xia HJ, Fu YP, Shen NN, Fu YM.
europepmc +1 more source
Transcriptional regulatory network analysis identifies conserved cis-antisense ncRNAs in the vancomycin and ceftriaxone stress response of <i>Enterococcus faecalis</i>. [PDF]
Pino-Gaete J +12 more
europepmc +1 more source
Vancomycin Prescribing in the Era of Vancomycin‐Resistant Enterococci [PDF]
openaire +2 more sources
A retrospective cohort study comparing the effects on inflammatory response and clinical outcomes of vancomycin-PMMA versus vancomycin-sulfate calcium in chronic osteomyelitis. [PDF]
Han S, Wu X, Wu T.
europepmc +1 more source
Clinical Approaches to <i>Clostridioides difficile</i> Infection Management: Insights From a Nationwide Survey of Korean Physicians. [PDF]
Moon JM +19 more
europepmc +1 more source
Vancomycin-piperacillin/tazobactam and acute kidney injury: a genuine clinical risk or an overstated association. [PDF]
Mehta A.
europepmc +1 more source
Vancomycin Therapeutic Drug Monitoring, Clinical Outcomes and Population Pharmacokinetic Model Evaluation in Neonates. [PDF]
Chung E, Tabbara N, Seto W, Shah V.
europepmc +1 more source

